During the past decade, St. Vincent's Medical Center conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 21 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 9 clinical trials were completed. i.e. 112.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Vincent's Medical Center" #1 sponsor was "Abbott Medical Devices" with 7 trials, followed by "Boston Scientific Corporation" with 7 trials sponsored, "NSABP Foundation Inc" with 5 trials sponsored, "National Cancer Institute (NCI)" with 5 trials sponsored and "AtriCure, Inc." with 5 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Vincent's Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator, "American College of Surgeons" with 2 trials as a collaborator, "Biosense Webster, Inc." with 2 trials as a collaborator and "North Central Cancer Treatment Group" with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "St. Vincent's Medical Center" are "Atrial Fibrillation" (9 trials), "Breast Cancer" (4 trials), "Heart Failure" (3 trials), "Paroxysmal Atrial Fibrillation" (3 trials) and "Persistent Atrial Fibrillation" (3 trials). Many other conditions were trialed in "St. Vincent's Medical Center" in a lesser frequency.

Most popular intervention types in "St. Vincent's Medical Center" are "Device" (34 trials), "Drug" (16 trials), "Other" (12 trials), "Biological" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (7 trials), "Laboratory Biomarker Analysis" (6 trials), "Paclitaxel" (6 trials), "Carboplatin" (4 trials) and "Cisplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "St. Vincent's Medical Center" are 40 trials for "All" genders and 12 trials for "Female" genders.

Currently, there are NaN active trials in "St. Vincent's Medical Center". undefined are not yet recruiting, 4 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in St. Vincent's Medical Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in St. Vincent's Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 26 trials that are defined as “Not Applicable".